Bilimsel çalışmalar

Prof. Dr. Evrim Metcalfe

21 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Gorken IB, Bayman E, Balci P, et al. Comparing Ultrasound with Computerized Tomography Images to Choose Electron Energy for Radiotherapy Boost Field in Breast Cancer Patients with Breast Conserving Surgery. J BUON. 2010;15(3):500-503.

    Kaynak: medicana.com.tr profil sayfası

  2. Etiz D, Bayman E, Akcay M, et al. Dosimetric and Clinical Predictors of Acute Esophagitis in Lung Cancer Patients in Turkey Treated with Radiotherapy. Asian Pac J Cancer Prev. 2013;14(7):4223-4228.

    Kaynak: medicana.com.tr profil sayfası

  3. Etiz D, Ataizi FC, Bayman E, et al. Prognostic Value of Osteopontin in Patients Treated with Primary Radiotherapy for Head and Neck Cancer. Asian Pac J Cancer Prev. 2013;14(9):5175-5178.

    Kaynak: medicana.com.tr profil sayfası

  4. Erpolat OP, Alco G, Caglar HB, et al. Comparison of Hematologic Toxicity Between 3DCRT and IMRT Planning in Cervical Cancer Patients After Concurrent Chemoradiotherapy: A National Multi-Center Study. Eur J Gynaecol Oncol. 2014;35(1):62-66.

    Kaynak: medicana.com.tr profil sayfası

  5. Bayman E, Prestwich RJ, Speight R, et al. Patterns of Failure After Intensity-Modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma Using Compartmental Clinical Target Volume Delineation. Clin Oncol (R Coll Radiol). 2014;26(10):636-642.

    Kaynak: medicana.com.tr profil sayfası

  6. Bayman E, Etiz D, Akcay M, Ak G. Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution in Turkey. Asian Pac J Cancer Prev. 2014;15(15):6264-6267.

    Kaynak: medicana.com.tr profil sayfası

  7. Murray L, Sethugavalar B, Robertshaw H, Bayman E, et al. Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks. Clin Oncol (R Coll Radiol). 2015;27(7):401-410.

    Kaynak: medicana.com.tr profil sayfası

  8. Bird D, Scarsbrook AF, Sykes J, et al. Multimodality Imaging with CT, MR and FDG-PET for Radiotherapy Target Volume Delineation in Oropharyngeal Squamous Cell Carcinoma. BMC Cancer. 2015;15:844.

    Kaynak: medicana.com.tr profil sayfası

  9. Metcalfe E, Etiz D. Early Transient Radiation-Induced Brachial Plexopathy in Locally Advanced Head and Neck Cancer. Contemp Oncol (Pozn). 2016;20(1):67-72.

    Kaynak: medicana.com.tr profil sayfası

  10. Metcalfe E, Karaoglanoglu O, Akyazici E. Radiotherapy with or without Temozolomide in Elderly Patients Aged ≥70 Years with Glioblastoma. Contemp Oncol (Pozn). 2016;20(3):251-255.

    Kaynak: medicana.com.tr profil sayfası

  11. Metcalfe E, Aspin L, Speight R, et al. Postoperative (Chemo)Radiotherapy for Oral Cavity Squamous Cell Carcinomas: Outcomes and Patterns of Failure. Clin Oncol (R Coll Radiol). 2017;29(1):51-59.

    Kaynak: medicana.com.tr profil sayfası

  12. Etiz D, Metcalfe E, Akcay M. Multiple Primary Malignant Neoplasms: A 10-Year Experience at a Single Institution from Turkey. J Cancer Res Ther. 2017;13(1):16-20.

    Kaynak: medicana.com.tr profil sayfası

  13. Metcalfe E, Arik D, Oge T, et al. CD105 (Endoglin) Expression as a Prognostic Marker of Angiogenesis in Squamous Cell Cervical Cancer Treated with Radical Radiotherapy. J Cancer Res Ther. 2018;14(6):1373-1378.

    Kaynak: medicana.com.tr profil sayfası

  14. Oktay E, Levent M, et al. Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): A Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). J Cancer Educ. 2020;35(1):69-75.

    Kaynak: medicana.com.tr profil sayfası

  15. Sert F, Metcalfe E, et al. Evaluation of the Radiation Oncologists’ Awareness and Needs about Geriatric Oncology: TROD-13-001 Study. Turk J Oncol. 2023;38(3):295-300. DOI:10.5505/tjo.2023.3978.

    Kaynak: medicana.com.tr profil sayfası

  16. Guzeloz Z, Gorken IB, et al. Evaluation of Treatment Outcomes and Tolerability in Older Patients with Rectal Cancer Treated with Radiotherapy Accompanied by the G-8 Geriatric Score: TROD13-003 Multicenter Study. J Geriatr Oncol. 2024;15(3):101739.

    Kaynak: medicana.com.tr profil sayfası

  17. Cetin IA, Halis H, et al. Definitive Radiotherapy/Chemoradiotherapy Outcomes and Toxicity Profile in Geriatric Patients with Cervical Cancer: Turkish Society for Radiation Oncology Geriatric Oncology Group Study (TROD 013-002). European Journal of Gynaecological Oncology. 2025;46(11):49-59. DOI:10.22514/ejgo.2025.137.

    Kaynak: medicana.com.tr profil sayfası

  18. Çağlar M, Akçay K, et al. Surface Dose Analysis and Dosimetric Comparison of Halcyon Versus Truebeam in Breast Cancer Radiotherapy: An OSL Dosimetry Study. J Appl Clin Med Phys. 2025:e70085. DOI:10.1002/acm2.70085.

    Kaynak: medicana.com.tr profil sayfası

  19. Çağlar M, Ertaş KS, et al. Synthetic CT Generation from CBCT Using Deep Learning for Adaptive Radiotherapy in Prostate Cancer. Front Radiol. 2025;5:1680803.

    Kaynak: medicana.com.tr profil sayfası

  20. Kirli Bolukbas M, Metcalfe E, et al. Determining Elderly-Friendly Radiation Oncology Clinics: A Comparative Analysis of Accessibility and Transport, Physical Environment, and Privacy Aspects (TROD 013-005). BMC Geriatr. 2025;26(1):118.

    Kaynak: medicana.com.tr profil sayfası

  21. Ergen ŞA, Dinçbaş FÖ, Metcalfe E, et al. Failure Patterns and the Influence of the TNM Staging Systems on Prognosis in Limited Disease Small Cell Lung Cancer (SCLC): The Turkish Oncology Group (TOG) Study. Clin Transl Oncol. 2025. DOI:10.1007/s12094-025-04092-9.

    Kaynak: medicana.com.tr profil sayfası